273 related articles for article (PubMed ID: 21708990)
21. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.
Beernink PT; Welsch JA; Bar-Lev M; Koeberling O; Comanducci M; Granoff DM
Infect Immun; 2008 Sep; 76(9):4232-40. PubMed ID: 18591239
[TBL] [Abstract][Full Text] [Related]
22. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
Madico G; Welsch JA; Lewis LA; McNaughton A; Perlman DH; Costello CE; Ngampasutadol J; Vogel U; Granoff DM; Ram S
J Immunol; 2006 Jul; 177(1):501-10. PubMed ID: 16785547
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.
Beernink PT; Granoff DM
Infect Immun; 2008 Jun; 76(6):2568-75. PubMed ID: 18362128
[TBL] [Abstract][Full Text] [Related]
24. Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies.
Seib KL; Brunelli B; Brogioni B; Palumbo E; Bambini S; Muzzi A; DiMarcello F; Marchi S; van der Ende A; Aricó B; Savino S; Scarselli M; Comanducci M; Rappuoli R; Giuliani MM; Pizza M
Infect Immun; 2011 Feb; 79(2):970-81. PubMed ID: 21149595
[TBL] [Abstract][Full Text] [Related]
25. Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergy.
Malito E; Lo Surdo P; Veggi D; Santini L; Stefek H; Brunelli B; Luzzi E; Bottomley MJ; Beernink PT; Scarselli M
Biochem J; 2016 Dec; 473(24):4699-4713. PubMed ID: 27784765
[TBL] [Abstract][Full Text] [Related]
26. Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.
Pajon R; Beernink PT; Granoff DM
Infect Immun; 2012 Aug; 80(8):2667-77. PubMed ID: 22615247
[TBL] [Abstract][Full Text] [Related]
27. Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity.
Natali EN; Principato S; Ferlicca F; Bianchi F; Fontana LE; Faleri A; Pansegrau W; Surdo PL; Bartolini E; Santini L; Brunelli B; Giusti F; Veggi D; Ferlenghi I; Norais N; Scarselli M
FASEB J; 2020 Aug; 34(8):10329-10341. PubMed ID: 32725956
[TBL] [Abstract][Full Text] [Related]
28. Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis.
Piet JR; Brouwer MC; Exley R; van der Veen S; van de Beek D; van der Ende A
PLoS One; 2012; 7(10):e47973. PubMed ID: 23110143
[TBL] [Abstract][Full Text] [Related]
29. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.
Johnson S; Tan L; van der Veen S; Caesar J; Goicoechea De Jorge E; Harding RJ; Bai X; Exley RM; Ward PN; Ruivo N; Trivedi K; Cumber E; Jones R; Newham L; Staunton D; Ufret-Vincenty R; Borrow R; Pickering MC; Lea SM; Tang CM
PLoS Pathog; 2012; 8(10):e1002981. PubMed ID: 23133374
[TBL] [Abstract][Full Text] [Related]
30. A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.
Konar M; Rossi R; Walter H; Pajon R; Beernink PT
PLoS One; 2015; 10(6):e0128185. PubMed ID: 26057742
[TBL] [Abstract][Full Text] [Related]
31. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.
Lewis LA; Ngampasutadol J; Wallace R; Reid JE; Vogel U; Ram S
PLoS Pathog; 2010 Jul; 6(7):e1001027. PubMed ID: 20686663
[TBL] [Abstract][Full Text] [Related]
32. Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein.
Beernink PT
Hum Vaccin Immunother; 2020 Mar; 16(3):703-712. PubMed ID: 31526219
[TBL] [Abstract][Full Text] [Related]
33. Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.
Tzeng YL; Giuntini S; Berman Z; Sannigrahi S; Granoff DM; Stephens DS
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958529
[TBL] [Abstract][Full Text] [Related]
34. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.
Faleri A; Santini L; Brier S; Pansegrau W; Lo Surdo P; Scarselli M; Buricchi F; Volpini G; Genovese A; van der Veen S; Lea S; Tang CM; Savino S; Pizza M; Finco O; Norais N; Masignani V
FASEB J; 2014 Apr; 28(4):1644-53. PubMed ID: 24371123
[TBL] [Abstract][Full Text] [Related]
35. A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbp.
Vu DM; Pajon R; Reason DC; Granoff DM
Sci Rep; 2012; 2():341. PubMed ID: 22461972
[TBL] [Abstract][Full Text] [Related]
36. Functional impacts of the diversity of the meningococcal factor H binding protein.
Hong E; Giorgini D; Deghmane AE; Taha MK
Vaccine; 2012 Dec; 31(1):183-9. PubMed ID: 23123023
[TBL] [Abstract][Full Text] [Related]
37. Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.
Lewis LA; Vu DM; Vasudhev S; Shaughnessy J; Granoff DM; Ram S
mBio; 2013 Oct; 4(5):e00339-13. PubMed ID: 24129254
[TBL] [Abstract][Full Text] [Related]
38. fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.
Giuntini S; Vu DM; Granoff DM
Vaccine; 2013 Aug; 31(38):4192-9. PubMed ID: 23791680
[TBL] [Abstract][Full Text] [Related]
39. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.
Rossi R; Granoff DM; Beernink PT
Vaccine; 2013 Nov; 31(46):5451-7. PubMed ID: 24035433
[TBL] [Abstract][Full Text] [Related]
40. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.
Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
